| Product Name | MF | CAS | Details |
|---|
| Pirimiphos ethyl | C13H24N3O3PS | 23505-41-1 | Details |
| DMPG (sodium) | C34H68NaO10P | 200880-40-6 | Details |
| Pyroxamide | C13H19N3O3 | 382180-17-8 | Details |
| NSP-DMAE-NHS | C30H26N2O9S | 194357-64-7 | Details |
| (S)-2-((S)-2-((S)-2-Amino-3-(4-hydroxyphenyl)propanamido)-3-(4-hydroxyphenyl)propanamido)-3-(4-hydroxyphenyl)propanoic acid | C27H29N3O7 | 7390-78-5 | Details |
| (4-(Ethylsulfonyl)phenyl)boronic acid | C8H11BO4S | 352530-24-6 | Details |
| Diphenamid | C16H17NO | 957-51-7 | Details |
| Methoxypolyethylene glycol maleimide (MW 2000) | (C2H4O)nC7H9NO3 | 99126-64-4 | Details |
| (R)-Bicalutamide | C18H14F4N2O4S | 113299-40-4 | Details |
| CaMKP inhibitor (sodium) | C10H8NNaO7S2 | 52789-62-5 | Details |
| 5-DTAF | C23H12Cl2N4O5 | 51306-35-5 | Details |
| Isazofos | C9H17ClN3O3PS | 42509-80-8 | Details |
| Valsartan Ethyl Ester | C26H33N5O3 | 1111177-30-0 | Details |
| Perfluorobutanesulfonamide | C4H2F9NO2S | 30334-69-1 | Details |
| 2,2-Bis(((2-cyano-3,3-diphenylacryloyl)oxy)methyl)propane-1,3-diyl bis(2-cyano-3,3-diphenylacrylate) | C69H48N4O8 | 178671-58-4 | Details |
| PSI-7976 | C22H29FN3O9P | 1190308-01-0 | Details |
| cis-10-Heptadecenoic acid | C17H32O2 | 29743-97-3 | Details |
| 8-Chloroadenosine | C10H12ClN5O4 | 34408-14-5 | Details |
| (2-(4-bromophenyl)ethene-1,1-diyl)dibenzene | C20H15Br | 18648-66-3 | Details |
| Cyclopentadienylmanganese(I) tricarbonyl | C8H5MnO35* | 12079-65-1 | Details |
| GR24 | C17H14O5 | 76974-79-3 | Details |
| Dimethyl Bromomalonate | C5H7BrO4 | 868-26-8 | Details |
| N-(5-(4-bromophenyl)-6-(2-hydroxyethoxy)pyrimidin-4-yl)propane-1-sulfamide | C15H19BrN4O4S | 1393813-43-8 | Details |
| Octabromobisphenol-S | C18H14Br8O4S | 42757-55-1 | Details |
| 5-Hydroxymethylcytosine | C5H7N3O2 | 1123-95-1 | Details |
| Cyanine | C29H35IN2 | 523-42-2 | Details |
| Sodium 2-((2-(stearoyloxy)propanoyl)oxy)propanoate | C24H45NaO6 | 25383-99-7 | Details |
| (Z)-hex-3-en-1-yl (Z)-hex-3-enoate, ≥95%, stabilized | C12H20O2 | 61444-38-0 | Details |
| (4R,12aS)-7-(Benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | C27H25F2N3O5 | 1206102-11-5 | Details |
| Galactinol | C12H22O11 | 3687-64-7 | Details |
| 1H,1H,2H,2H,3H,3H-Tridecafluoro-1-nonanol | C9H7F13O | 80806-68-4 | Details |
| β-D-Fructose,98%(mixtures) | C7H14O6 | 53188-23-1 | Details |
| Methyl mycophenolate | C18H22O6 | 31858-66-9 | Details |
| 1,2-Dimethyl-3,5-diphenyl-1H-pyrazol-2-ium | C17H17N2+ | 49866-87-7 | Details |
| Edoxaban impurity 4 | C21H30ClN5O5 | 480452-36-6 | Details |
| DOTAP (methylsulfate) | C42H80NO4.CH3O4S | 144189-73-1 | Details |
| Chlorodimethyl(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-n-octyl)silane | C10H10ClF13Si | 102488-47-1 | Details |
| 11-((2,3-Dihydroxypropoxy)carbonyl)heptadecanoate | C21H39O6- | 73398-61-5 | Details |
| Perilloxin | C16H18O4 | 263249-77-0 | Details |
| 1-Phenyl-2,2,2-trifluoroethanol | C8H7F3O | 340-05-6 | Details |
| Mepronil | C17H19NO2 | 55814-41-0 | Details |
| Boc-Ala-D-Glu(OBzl)-NH2 | C20H29N3O6 | 18814-49-8 | Details |
| Sodium (E)-2,4-dimethyl-5-((1-oxido-4-sulfonaphthalen-2-yl)diazenyl)benzenesulfonate | C18H17N2NaO7S2 | 4548-53-2 | Details |
| FAAH/MAGL-IN-4 | C15H25BO2 | 256383-45-6 | Details |
| Ethyl trans-caffeate | C11H12O4 | 66648-50-8 | Details |
| trans-Caffeic acid | C9H8O4 | 501-16-6 | Details |
| NAD (sodium) | C21H28N7NaO14P2 | 20111-18-6 | Details |
| Cimbuterol | C13H19N3O | 54239-39-3 | Details |
| Ipragliflozin (L-Proline) | C21H21FO5S.C5H9NO2 | 951382-34-6 | Details |
| Trietazine | C9H16ClN5 | 1912-26-1 | Details |
| (R)-Citalopram (oxalate) | C22H23FN2O5 | 219861-53-7 | Details |
| Methiocarb | C11H15NO2S | 2032-65-7 | Details |
| 6-Hydroxy-L-DOPA | C9H11NO5 | 27244-64-0 | Details |
| Nelociguat | C19H17FN8O2 | 625115-52-8 | Details |
| 4,4'-Oxybis(phenoxybenzene) | C24H18O3 | 3379-41-7 | Details |
| N-(2,4-dimethylphenyl)-3-hydroxy-4-((2-hydroxyphenyl)diazenyl)-2-naphthamide | C25H21N3O3 | 523-67-1 | Details |
| Dimethyl octafluoroadipate | C8H6F8O4 | 3107-98-0 | Details |
| C6 NBD Ceramide | C30H49N5O6 | 94885-02-6 | Details |
| 3-Desacetyl Cefotaxime lactone | C14H13N5O5S2 | 66340-33-8 | Details |
| (6S,9R)-6-(4-Hydroxybenzyl)-2,2,9-trimethyl-4,7,10-trioxo-3-oxa-5,8,11-triazatridecan-13-oic acid | C19H27N3O7 | 64410-47-5 | Details |
| Benfuracarb | C20H30N2O5S | 82560-54-1 | Details |
| Bis(2-propylheptyl) phthalate | C28H46O4 | 53306-54-0 | Details |
| 8-Prenyldaidzein | C20H18O4 | 135384-00-8 | Details |
| 7-Fluorobenzofurazan-4-sulfonic acid (ammonium) | C6H6FN3O4S | 84806-27-9 | Details |
| N2-(sec-butyl)-N4-ethyl-6-methoxy-1,3,5-triazine-2,4-diamine | C10H19N5O | 26259-45-0 | Details |
| Adenosine 3′-monophosphate | C10H14N5O7P | 84-21-9 | Details |
| 1-Oleoyl-sn-glycero-3-phosphocholine | C26H52NO7P | 19420-56-5 | Details |
| α-Irone, 97% | C14H22O | 79-69-6 | Details |
| 3-(1,1,2,2-Tetrafluoroethoxy)benzoic acid | C9H6F4O3 | 70126-48-6 | Details |
| Moronic acid | C30H46O3 | 6713-27-5 | Details |
| L-Prolyl-L-leucine | C11H20N2O3 | 52899-07-7 | Details |
| 10,10'-Oxybis(phenoxarsine) | C24H16As2O3 | 58-36-6 | Details |
| Laminaribiose | C12H22O11 | 34980-39-7 | Details |
| Sedoheptulose anhydride | C7H12O6 | 469-90-9 | Details |
| Thymolphthalexon (tetrasodium) | C38H45N2NaO12 | 62698-55-9 | Details |
| Cyclic GMP | C10H12N5O7P | 7665-99-8 | Details |
| Dipropetryn | C11H21N5S | 4147-51-7 | Details |
| Furalaxyl | C17H19NO4 | 57646-30-7 | Details |
| Cimetidine sulfoxide | C10H16N6OS | 54237-72-8 | Details |
| Bis(1,2,2,6,6-pentamethylpiperidin-4-yl) 2-butyl-2-(3,5-di-tert-butyl-4-hydroxybenzyl)malonate | C42H72N2O5 | 63843-89-0 | Details |
| (E)-1,1-Dimethoxy-3,7-dimethylocta-2,6-diene, ≥90% | C12H22O2 | 7549-37-3 | Details |
| Methiocarb sulfone | C11H15NO4S | 2179-25-1 | Details |
| Fenpropimorph | C20H33NO | 67564-91-4 | Details |
| 14H-benzo[c]benzo[4,5]thieno[2,3-a]carbazole | C22H13NS | 1313395-18-4 | Details |
| Cefuracetime | C17H17N3O8S | 39685-31-9 | Details |
| Difenoxuron | C16H18N2O3 | 14214-32-5 | Details |
| Chlorophosphonazo mA | C24H18ClN4O12PS2 | 86167-87-5 | Details |
| Gitoxin | C41H64O14 | 4562-36-1 | Details |
| Dec-3-en-2-one, predominantly trans, ≥97%, stabilized | C10H18O | 10519-33-2 | Details |
| Dioctyltin dichloride | C16H34Cl2Sn | 3542-36-7 | Details |
| Glycidamide | C3H5NO2 | 5694-00-8 | Details |
| S-Adenosyl-L-methionine (chloride dihydrochloride) | C15H24Cl2N6O5S | 86867-01-8 | Details |
| Ti2AlC MAX phase ceramic material | 12537-81-4 | Details |
| Vanadium aluminum carbide (V2AlC) MAX phase ceramic material | CV | 12070-10-9 | Details |
| (1R,3S,Z)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S)-5,6-Dimethylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol | C28H46O2 | 143032-85-3 | Details |
| (4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | C21H21F2N3O5 | 1335210-35-9 | Details |
| 4-Acetoxycinnamic acid | C11H10O4 | 15486-19-8 | Details |
| Cambendazole | C14H14N4O2S | 26097-80-3 | Details |
| Dizocilpine | C16H15N | 77086-21-6 | Details |
| 1,4-Dichlorobenzene-d4 | C6Cl2D4 | 3855-82-1 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 | ||||